DermTech, Inc.
DMTKQ
$0.00
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.66M | 15.30M | 14.37M | 14.02M | 14.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.66M | 15.30M | 14.37M | 14.02M | 14.28M |
| Cost of Revenue | 14.33M | 15.02M | 14.89M | 14.84M | 14.14M |
| Gross Profit | 1.33M | 276.00K | -520.00K | -813.00K | 139.00K |
| SG&A Expenses | 73.94M | 83.28M | 89.86M | 96.91M | 98.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 102.37M | 113.54M | 121.73M | 130.84M | 134.30M |
| Operating Income | -86.70M | -98.24M | -107.37M | -116.82M | -120.02M |
| Income Before Tax | -89.63M | -100.89M | -110.02M | -119.63M | -117.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -89.63 | -100.89 | -110.02 | -119.63 | -117.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -89.63M | -100.89M | -110.02M | -119.63M | -117.85M |
| EBIT | -86.70M | -98.24M | -107.37M | -116.82M | -120.02M |
| EBITDA | -84.85M | -96.42M | -105.54M | -115.01M | -118.29M |
| EPS Basic | -2.69 | -3.13 | -3.51 | -3.90 | -3.90 |
| Normalized Basic EPS | -1.57 | -1.85 | -2.09 | -2.33 | -2.44 |
| EPS Diluted | -2.70 | -3.14 | -3.52 | -3.91 | -3.91 |
| Normalized Diluted EPS | -1.57 | -1.85 | -2.09 | -2.33 | -2.44 |
| Average Basic Shares Outstanding | 134.66M | 130.51M | 126.43M | 122.69M | 120.86M |
| Average Diluted Shares Outstanding | 134.66M | 130.51M | 126.43M | 122.69M | 120.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |